| 000 | 01514 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513090647.0 | ||
| 264 | 0 | _c19960625 | |
| 008 | 199606s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199606133342404 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBishai, W R | |
| 245 | 0 | 0 |
_aBrief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJun 1996 |
||
| 300 |
_a1573-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBacteriological Techniques |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aDNA, Bacterial _xanalysis |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 700 | 1 | _aGraham, N M | |
| 700 | 1 | _aHarrington, S | |
| 700 | 1 | _aPage, C | |
| 700 | 1 | _aMoore-Rice, K | |
| 700 | 1 | _aHooper, N | |
| 700 | 1 | _aChaisson, R E | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 334 _gno. 24 _gp. 1573-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199606133342404 _zAvailable from publisher's website |
| 999 |
_c8627383 _d8627383 |
||